Polyrizon

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Polyrizon and other ETFs, options, and stocks.

About PLRZ

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. 

CEO
Tomer Izraeli
CEOTomer Izraeli
Employees
6
Employees6
Headquarters
Raanana, Tel Aviv
HeadquartersRaanana, Tel Aviv
Founded
2005
Founded2005
Employees
6
Employees6

PLRZ Key Statistics

Market cap
21.36M
Market cap21.36M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
90.73K
Average volume90.73K
High today
$13.50
High today$13.50
Low today
$12.03
Low today$12.03
Open price
$13.46
Open price$13.46
Volume
58.90K
Volume58.90K
52 Week high
$2,235.00
52 Week high$2,235.00
52 Week low
$2.88
52 Week low$2.88

Stock Snapshot

With a market cap of 21.36M, Polyrizon(PLRZ) trades at $13.20. The stock has a price-to-earnings ratio of -0.04.

On 2026-02-09, Polyrizon(PLRZ) stock traded between a low of $12.03 and a high of $13.50. Shares are currently priced at $13.20, which is +9.7% above the low and -2.2% below the high.

Polyrizon(PLRZ) shares are trading with a volume of 58.9K, against a daily average of 90.73K.

In the last year, Polyrizon(PLRZ) shares hit a 52-week high of $2,235.00 and a 52-week low of $2.88.

In the last year, Polyrizon(PLRZ) shares hit a 52-week high of $2,235.00 and a 52-week low of $2.88.

PLRZ News

TipRanks 3d
Polyrizon and Clearmind Partner on Intranasal Non-Hallucinogenic Neuroplastogen MEAI

Polyrizon Ltd. ( (PLRZ) ) has shared an update. On February 6, 2026, Polyrizon Ltd. announced it had signed a development agreement with Clearmind Medicine Inc...

TipRanks 3d
Clearmind, Polyrizon enter development agreement for intranasal MEAI formulation

Polyrizon (PLRZ) entered into a development agreement with Clearmind Medicine (CMND). Under this agreement, Polyrizon will develop a proprietary intranasal form...

TipRanks 5d
Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Polyrizon ( PLRZ...

More PLRZ News

TipRanks 5d
Polyrizon Moves to Acquire 51% Stake in Global Private Aviation Firm Arrow Aviation

The latest update is out from Polyrizon Ltd. ( (PLRZ) ). On February 4, 2026, Polyrizon Ltd. announced it has signed a non-binding memorandum of understanding...

People also own

Based on the portfolios of people who own PLRZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.